BACKGROUND: Proton beam radiation therapy (PBRT) has dosimetric advantages compared to photon radiation therapy for the treatment of major salivary gland tumors (MSGTs). METHODS: Patients with non-metastatic MSGTs treated at a single proton therapy center from October 2013 to October 2018 were retrospectively reviewed. RESULTS: Sixty-eight patients with MSGTs were included and the most common site and histology were the parotid gland (75.0%) and adenoid cystic carcinoma (22.1%), respectively. The 3-year rates of locoregional control, progression-free survival, and overall survival were 95.1% (95% CI: 89.9%-100.0%), 80.7% (70.2%-92.7%), and 96.1% (95% CI: 90.9%-100.0%), respectively. CONCLUSION: In a large cohort of MSGTs treated with PBRT, the rates of locoregional control were high in short-term follow-up and treatment was well tolerated.
BACKGROUND: Proton beam radiation therapy (PBRT) has dosimetric advantages compared to photon radiation therapy for the treatment of major salivary gland tumors (MSGTs). METHODS: Patients with non-metastatic MSGTs treated at a single proton therapy center from October 2013 to October 2018 were retrospectively reviewed. RESULTS: Sixty-eight patients with MSGTs were included and the most common site and histology were the parotid gland (75.0%) and adenoid cystic carcinoma (22.1%), respectively. The 3-year rates of locoregional control, progression-free survival, and overall survival were 95.1% (95% CI: 89.9%-100.0%), 80.7% (70.2%-92.7%), and 96.1% (95% CI: 90.9%-100.0%), respectively. CONCLUSION: In a large cohort of MSGTs treated with PBRT, the rates of locoregional control were high in short-term follow-up and treatment was well tolerated.
Authors: V L Vander Poorten; A J Balm; F J Hilgers; I B Tan; B M Loftus-Coll; R B Keus; F E van Leeuwen; A A Hart Journal: Cancer Date: 1999-05-01 Impact factor: 6.860
Authors: Alexandra D Jensen; Anna V Nikoghosyan; Karen Lossner; Thomas Haberer; Oliver Jäkel; Marc W Münter; Jürgen Debus Journal: Int J Radiat Oncol Biol Phys Date: 2015-05-19 Impact factor: 7.038
Authors: Jonathan E Leeman; Paul B Romesser; Ying Zhou; Sean McBride; Nadeem Riaz; Eric Sherman; Marc A Cohen; Oren Cahlon; Nancy Lee Journal: Lancet Oncol Date: 2017-04-26 Impact factor: 41.316
Authors: Naresh Jegadeesh; Yuan Liu; Roshan S Prabhu; Kelly R Magliocca; David M Marcus; Kristin A Higgins; Jeffrey M Vainshtein; J Trad Wadsworth; Jonathan J Beitler Journal: Oral Oncol Date: 2015-05-29 Impact factor: 5.337
Authors: A S Garden; A K el-Naggar; W H Morrison; D L Callender; K K Ang; L J Peters Journal: Int J Radiat Oncol Biol Phys Date: 1997-01-01 Impact factor: 7.038
Authors: Allen M Chen; M Kara Bucci; Vivian Weinberg; Joaquin Garcia; Jeanne M Quivey; Naomi R Schechter; Theodore L Phillips; Karen K Fu; David W Eisele Journal: Int J Radiat Oncol Biol Phys Date: 2006-09-01 Impact factor: 7.038
Authors: Safina Ali; Frank L Palmer; Changhong Yu; Monica DiLorenzo; Jatin P Shah; Michael W Kattan; Snehal G Patel; Ian Ganly Journal: Ann Surg Oncol Date: 2013-10-17 Impact factor: 5.344
Authors: Irini Youssef; Jennifer Yoon; Nader Mohamed; Kaveh Zakeri; Robert H Press; Yao Yu; Jung Julie Kang; Richard J Wong; R Michael Tuttle; Ashok Shaha; Eric Sherman; Nancy Y Lee Journal: Int J Part Ther Date: 2022-07-15